PMC:7212965 / 18474-19341 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T69","span":{"begin":39,"end":47},"obj":"Disease"},{"id":"T70","span":{"begin":404,"end":412},"obj":"Disease"},{"id":"T71","span":{"begin":578,"end":586},"obj":"Disease"},{"id":"T72","span":{"begin":842,"end":850},"obj":"Disease"}],"attributes":[{"id":"A69","pred":"mondo_id","subj":"T69","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A70","pred":"mondo_id","subj":"T70","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"},{"id":"A71","pred":"mondo_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"},{"id":"A72","pred":"mondo_id","subj":"T72","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"}],"text":"A total of 43 studies including 10,676 COVID-19 patients (confirmed by laboratory real-time reverse transcription polymerase chain reaction [RT-PCR] testing) were included in the overall analysis.20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35 , 37 , 38 , 41 , 42 , 45 , 47 , 49, 50, 51, 52, 53, 54, 55 , 58 , 59 , 62, 63, 64, 65, 66, 67, 68, 69, 70, 71 , 73 , 76 The pooled prevalence of diarrhea symptoms across these studies was 7.7% (95% CI, 7.2%–8.2%). When analyzing by country (studies from China vs studies from other countries), the pooled prevalence of diarrhea in studies from countries other than China was much higher at 18.3% (95% CI, 16.6%–20.1%). This is in comparison to studies from China, where the prevalence was much lower at 5.8% (95% CI, 5.3%–6.4%) (Figure 1 ).\nFigure 1 Forest plot of the prevalence of diarrhea in all patients."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T123","span":{"begin":0,"end":1},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T124","span":{"begin":149,"end":156},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T125","span":{"begin":204,"end":206},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T126","span":{"begin":224,"end":226},"obj":"http://purl.obolibrary.org/obo/CLO_0050509"},{"id":"T127","span":{"begin":252,"end":254},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"},{"id":"T128","span":{"begin":256,"end":258},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T129","span":{"begin":271,"end":273},"obj":"http://purl.obolibrary.org/obo/CLO_0053794"},{"id":"T130","span":{"begin":281,"end":283},"obj":"http://purl.obolibrary.org/obo/CLO_0053799"},{"id":"T131","span":{"begin":303,"end":305},"obj":"http://purl.obolibrary.org/obo/CLO_0001407"},{"id":"T132","span":{"begin":366,"end":368},"obj":"http://purl.obolibrary.org/obo/CLO_0054055"}],"text":"A total of 43 studies including 10,676 COVID-19 patients (confirmed by laboratory real-time reverse transcription polymerase chain reaction [RT-PCR] testing) were included in the overall analysis.20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35 , 37 , 38 , 41 , 42 , 45 , 47 , 49, 50, 51, 52, 53, 54, 55 , 58 , 59 , 62, 63, 64, 65, 66, 67, 68, 69, 70, 71 , 73 , 76 The pooled prevalence of diarrhea symptoms across these studies was 7.7% (95% CI, 7.2%–8.2%). When analyzing by country (studies from China vs studies from other countries), the pooled prevalence of diarrhea in studies from countries other than China was much higher at 18.3% (95% CI, 16.6%–20.1%). This is in comparison to studies from China, where the prevalence was much lower at 5.8% (95% CI, 5.3%–6.4%) (Figure 1 ).\nFigure 1 Forest plot of the prevalence of diarrhea in all patients."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T66","span":{"begin":404,"end":412},"obj":"Phenotype"},{"id":"T67","span":{"begin":578,"end":586},"obj":"Phenotype"},{"id":"T68","span":{"begin":842,"end":850},"obj":"Phenotype"}],"attributes":[{"id":"A66","pred":"hp_id","subj":"T66","obj":"http://purl.obolibrary.org/obo/HP_0002014"},{"id":"A67","pred":"hp_id","subj":"T67","obj":"http://purl.obolibrary.org/obo/HP_0002014"},{"id":"A68","pred":"hp_id","subj":"T68","obj":"http://purl.obolibrary.org/obo/HP_0002014"}],"text":"A total of 43 studies including 10,676 COVID-19 patients (confirmed by laboratory real-time reverse transcription polymerase chain reaction [RT-PCR] testing) were included in the overall analysis.20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35 , 37 , 38 , 41 , 42 , 45 , 47 , 49, 50, 51, 52, 53, 54, 55 , 58 , 59 , 62, 63, 64, 65, 66, 67, 68, 69, 70, 71 , 73 , 76 The pooled prevalence of diarrhea symptoms across these studies was 7.7% (95% CI, 7.2%–8.2%). When analyzing by country (studies from China vs studies from other countries), the pooled prevalence of diarrhea in studies from countries other than China was much higher at 18.3% (95% CI, 16.6%–20.1%). This is in comparison to studies from China, where the prevalence was much lower at 5.8% (95% CI, 5.3%–6.4%) (Figure 1 ).\nFigure 1 Forest plot of the prevalence of diarrhea in all patients."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T4","span":{"begin":92,"end":113},"obj":"http://purl.obolibrary.org/obo/GO_0001171"},{"id":"T5","span":{"begin":100,"end":113},"obj":"http://purl.obolibrary.org/obo/GO_0006351"}],"text":"A total of 43 studies including 10,676 COVID-19 patients (confirmed by laboratory real-time reverse transcription polymerase chain reaction [RT-PCR] testing) were included in the overall analysis.20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35 , 37 , 38 , 41 , 42 , 45 , 47 , 49, 50, 51, 52, 53, 54, 55 , 58 , 59 , 62, 63, 64, 65, 66, 67, 68, 69, 70, 71 , 73 , 76 The pooled prevalence of diarrhea symptoms across these studies was 7.7% (95% CI, 7.2%–8.2%). When analyzing by country (studies from China vs studies from other countries), the pooled prevalence of diarrhea in studies from countries other than China was much higher at 18.3% (95% CI, 16.6%–20.1%). This is in comparison to studies from China, where the prevalence was much lower at 5.8% (95% CI, 5.3%–6.4%) (Figure 1 ).\nFigure 1 Forest plot of the prevalence of diarrhea in all patients."}

{"project":"2_test","denotations":[{"id":"32407808-32171076-43469255","span":{"begin":196,"end":198},"obj":"32171076"},{"id":"32407808-32107577-43469256","span":{"begin":232,"end":234},"obj":"32107577"},{"id":"32407808-32241899-43469257","span":{"begin":315,"end":317},"obj":"32241899"},{"id":"32407808-32519944-43469258","span":{"begin":354,"end":356},"obj":"32519944"},{"id":"32407808-32149037-43469259","span":{"begin":358,"end":360},"obj":"32149037"}],"text":"A total of 43 studies including 10,676 COVID-19 patients (confirmed by laboratory real-time reverse transcription polymerase chain reaction [RT-PCR] testing) were included in the overall analysis.20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35 , 37 , 38 , 41 , 42 , 45 , 47 , 49, 50, 51, 52, 53, 54, 55 , 58 , 59 , 62, 63, 64, 65, 66, 67, 68, 69, 70, 71 , 73 , 76 The pooled prevalence of diarrhea symptoms across these studies was 7.7% (95% CI, 7.2%–8.2%). When analyzing by country (studies from China vs studies from other countries), the pooled prevalence of diarrhea in studies from countries other than China was much higher at 18.3% (95% CI, 16.6%–20.1%). This is in comparison to studies from China, where the prevalence was much lower at 5.8% (95% CI, 5.3%–6.4%) (Figure 1 ).\nFigure 1 Forest plot of the prevalence of diarrhea in all patients."}

{"project":"LitCovid-sentences","denotations":[{"id":"T137","span":{"begin":0,"end":472},"obj":"Sentence"},{"id":"T138","span":{"begin":473,"end":677},"obj":"Sentence"},{"id":"T139","span":{"begin":678,"end":799},"obj":"Sentence"},{"id":"T140","span":{"begin":800,"end":867},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A total of 43 studies including 10,676 COVID-19 patients (confirmed by laboratory real-time reverse transcription polymerase chain reaction [RT-PCR] testing) were included in the overall analysis.20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35 , 37 , 38 , 41 , 42 , 45 , 47 , 49, 50, 51, 52, 53, 54, 55 , 58 , 59 , 62, 63, 64, 65, 66, 67, 68, 69, 70, 71 , 73 , 76 The pooled prevalence of diarrhea symptoms across these studies was 7.7% (95% CI, 7.2%–8.2%). When analyzing by country (studies from China vs studies from other countries), the pooled prevalence of diarrhea in studies from countries other than China was much higher at 18.3% (95% CI, 16.6%–20.1%). This is in comparison to studies from China, where the prevalence was much lower at 5.8% (95% CI, 5.3%–6.4%) (Figure 1 ).\nFigure 1 Forest plot of the prevalence of diarrhea in all patients."}

{"project":"LitCovid-PubTator","denotations":[{"id":"384","span":{"begin":858,"end":866},"obj":"Species"},{"id":"385","span":{"begin":842,"end":850},"obj":"Disease"},{"id":"390","span":{"begin":48,"end":56},"obj":"Species"},{"id":"391","span":{"begin":39,"end":47},"obj":"Disease"},{"id":"392","span":{"begin":404,"end":412},"obj":"Disease"},{"id":"393","span":{"begin":578,"end":586},"obj":"Disease"}],"attributes":[{"id":"A384","pred":"tao:has_database_id","subj":"384","obj":"Tax:9606"},{"id":"A385","pred":"tao:has_database_id","subj":"385","obj":"MESH:D003967"},{"id":"A390","pred":"tao:has_database_id","subj":"390","obj":"Tax:9606"},{"id":"A391","pred":"tao:has_database_id","subj":"391","obj":"MESH:C000657245"},{"id":"A392","pred":"tao:has_database_id","subj":"392","obj":"MESH:D003967"},{"id":"A393","pred":"tao:has_database_id","subj":"393","obj":"MESH:D003967"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"A total of 43 studies including 10,676 COVID-19 patients (confirmed by laboratory real-time reverse transcription polymerase chain reaction [RT-PCR] testing) were included in the overall analysis.20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35 , 37 , 38 , 41 , 42 , 45 , 47 , 49, 50, 51, 52, 53, 54, 55 , 58 , 59 , 62, 63, 64, 65, 66, 67, 68, 69, 70, 71 , 73 , 76 The pooled prevalence of diarrhea symptoms across these studies was 7.7% (95% CI, 7.2%–8.2%). When analyzing by country (studies from China vs studies from other countries), the pooled prevalence of diarrhea in studies from countries other than China was much higher at 18.3% (95% CI, 16.6%–20.1%). This is in comparison to studies from China, where the prevalence was much lower at 5.8% (95% CI, 5.3%–6.4%) (Figure 1 ).\nFigure 1 Forest plot of the prevalence of diarrhea in all patients."}